目的 探究恒古骨伤愈合剂联合维生素D滴剂治疗Gartland I -II型稳定性儿童肱骨髁上骨折的临床疗效。方法 研究患儿选自2024年6月—2024年12月山西省儿童医院收治的100例Gartland I-II型稳定型肱骨髁上骨折患儿，依据治疗方案不同将患儿分为对照组和治疗组，每组各50例。所有患儿均给予手法复位、石膏托外固定及常规功能性训练。对照组早上或餐后服用维生素D滴剂，1～2粒/次，每日1次。治疗组在对照组基础上饭后服用恒古骨伤愈合剂，6岁≤患儿年龄≤12岁，隔日1次，每次12 mL；12岁＜患儿年龄≤14岁，隔日1次，每次15 mL。两组患儿均治疗4周。观察两组的临床疗效，比较两组患肢功能、骨折愈合、恢复相关指标、影像学指标和肘关节功能评分和疼痛程度。结果 治疗后，治疗组患儿患肢功能优良率是98.00%，显著高于对照组的84.00%（P＜0.05）。治疗组患儿骨折愈合时间、肘关节肿胀缓解时间、开始活动时间均短于对照组，差异有统计学意义（P＜0.05）。治疗后，两组过伸角降低，而屈曲角、关节活动度（ROM）、Baumann角均较治疗前增加（P＜0.05）；治疗后，治疗组过伸角低于对照组，屈曲角、ROM、Baumann角高于对照组（P＜0.05）。两组治疗后视觉模拟评分（VAS）显著降低，Mayo肘关节功能评分升高（P＜0.05）；治疗后，治疗组VAS评分低于对照组，Mayo肘关节功能评分高于对照组（P＜0.05）。治疗过程中，治疗组患者并发症发生率是4.00%，显著低于对照组的16.00%（P＜0.05）。结论 针对Gartland I-II型稳定性肱骨髁上骨折患儿给予恒古骨伤愈合剂联合维生素D滴剂，可以促进患儿患肢功能及肘关节功能恢复，改善患肢活动度与疼痛程度，且利于降低并发症风险。

Objective To explore the clinical efficacy of OSTEOKING combined with Vitamin D Drops in treatment of Gartland type I-II stable supracondylar fractures of the humerus in children. Methods A total of 100 children with Gartland type I-II stable supracondylar fractures of humerus admitted to Shanxi Children’s Hospital from June 2024 to December 2024 were selected for the study. According to different treatment regimens, the children were divided into control group and treatment group, with 50 cases in each group. All the children patients were given manual reduction, external fixation with plaster casts and routine functional training. Children in control group took Vitamin D Drops in morning or after meals, 1 to 2 capsules each time, once daily. Children in treatment group took OSTEOKING after meals on the basis of control group, for children aged 6 to 12 years old, the dosage was 12 mL every other day, for children aged 12 to 14 years old, administer 15 mL every other day. Both groups of children were treated for 4 weeks. The clinical efficacy of two groups was observed, and the functions of affected limbs, fracture healing, recovery-related indicators, imaging indicators, elbow joint function scores and pain degrees between two groups were compared. Results After treatment, the excellent and good rate of affected limb function in treatment group was 98.00%, significantly higher than 84.00% in control group (P < 0.05). The fracture healing time, elbow joint swelling relief time and the time to start activities of children in treatment group were all shorter than those in control group, and the differences were statistically significant (P < 0.05). After treatment, the hyperextension angles in both groups decreased, but the flexion angles, range of motion (ROM), and Baumann angles all increased compared with those before treatment (P < 0.05). After treatment, the hyperextension angle of treatment group was lower than that of control group, but the flexion angle, ROM and Baumann angle were higher than those of control group (P < 0.05). After treatment in both groups, the VAS score significantly decreased, and the Mayo elbow function score increased (P< 0.05). After treatment, VAS score of treatment group was lower than that of control group, but the Mayo elbow joint function score was higher than that of control group (P < 0.05). During the treatment process, the incidence of complications in treatment group was 4.00%, significantly lower than 16.00% in control group (P < 0.05). Conclusion For children with Gartland type I-II stable supracondylar fractures of the humerus, OSTEOKING combined with Vitamin D Drops can promote the recovery of affected limb function and elbow joint function, improve the range of motion and pain degree of affected limb, and help reduce the risk of complications.

R982

山西省教育厅科研基金（2022L198）